Compounds > 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile
Page last updated: 2024-09-04

2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile and bedaquiline

2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile has been researched along with bedaquiline in 1 studies

Compound Research Comparison

Studies
(2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile)		Trials
(2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile)		Recent Studies (post-2010)
(2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile)		Studies
(bedaquiline)		Trials
(bedaquiline)		Recent Studies (post-2010) (bedaquiline)
130670441630

Protein Interaction Comparison

ProteinTaxonomy2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (IC50)bedaquiline (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 24.36
Cytochrome P450 2C19Homo sapiens (human)1.6
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.2486
ATP synthase subunit c Mycolicibacterium smegmatis0.0119
Sigma intracellular receptor 2Rattus norvegicus (Norway rat)1.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Franzblau, S; Lee, BS; Liu, R; Ma, R; Markley, L; Mikušová, K; Miller, MJ; Miller, PA; Moraski, GC; Pethe, K; Savková, K; Shetye, G1

Other Studies

1 other study(ies) available for 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile and bedaquiline

ArticleYear
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds.
    RSC medicinal chemistry, 2021, Jan-01, Volume: 12, Issue:1

    Topics:

2021